4587.T
Price:
$1748
Market Cap:
$225.77B
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
Industry
Biotechnology
IPO Date
2013-06-12
Stock Exchange
JPX
Ticker
4587.T
According to PeptiDream Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 15.31. This represents a change of -116.71% compared to the average of -91.62 of the last 4 quarters.
The mean historical PE Ratio of PeptiDream Inc. over the last ten years is 56.46. The current 15.31 PE Ratio has changed 2.61% with respect to the historical average. Over the past ten years (40 quarters), 4587.T's PE Ratio was at its highest in in the September 2018 quarter at 4.27K. The PE Ratio was at its lowest in in the September 2019 quarter at -866.47.
Average
56.46
Median
119.50
Minimum
-717.49
Maximum
254.25
Discovering the peaks and valleys of PeptiDream Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.92%
Maximum Annual PE Ratio = 254.25
Minimum Annual Increase = -382.20%
Minimum Annual PE Ratio = -717.49
Year | PE Ratio | Change |
---|---|---|
2024 | 22.83 | -64.06% |
2023 | 63.51 | 77.92% |
2022 | 35.70 | -60.76% |
2021 | 90.97 | -38.55% |
2020 | 148.03 | -120.63% |
2019 | -717.49 | -382.20% |
2019 | 254.25 | 6.73% |
2018 | 238.20 | 10.85% |
2017 | 214.89 | 0.56% |
2016 | 213.69 | 14.39% |
The current PE Ratio of PeptiDream Inc. (4587.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
40.68
5-year avg
72.21
10-year avg
56.46
PeptiDream Inc.’s PE Ratio is less than M3, Inc. (32.74), greater than Shionogi & Co., Ltd. (11.20), less than Chugai Pharmaceutical Co., Ltd. (30.20), less than Nihon M&A Center Holdings Inc. (18.87), greater than Takara Bio Inc. (-1808.55),
Company | PE Ratio | Market cap |
---|---|---|
32.74 | $1.34T | |
11.20 | $1.89T | |
30.20 | $12.39T | |
18.87 | $206.70B | |
-1808.55 | $94.04B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PeptiDream Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PeptiDream Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PeptiDream Inc.'s PE Ratio?
How is the PE Ratio calculated for PeptiDream Inc. (4587.T)?
What is the highest PE Ratio for PeptiDream Inc. (4587.T)?
What is the 3-year average PE Ratio for PeptiDream Inc. (4587.T)?
What is the 5-year average PE Ratio for PeptiDream Inc. (4587.T)?
How does the current PE Ratio for PeptiDream Inc. (4587.T) compare to its historical average?